Market Update Graphic
Source: The Market Online
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Christmas is fast approaching and the ASX200 has been down 0.35% at 8,267 points. The Santa rally has so far failed to materialise as the latest round of Chinese stimulus underwhelmed investors.

The Iron Ore price is steady at around US$103.75 per tonne in Singapore after sliding on the weekend.

Materials has been the poorest performing sector, down 1.6%, followed by IT and Real Estate, both down around 0.65%.

Utilities has been the best, up 0.3%, followed by Industrials and Financials, up 0.2%.

Company News

Online retailer Kogan (ASX:KGN) has been down 1% on the news ASIC is investigating a potentially controversial options deal involving two of its senior executives, including founder Ruslan Kogan. The deal netted $17 million in profits for the executives and the company is cooperating with the investigation.

Kogan has been $5.60.

Fortescue (ASX:FMG) has been down 2.4% as analysts at Bell Potter retain their Sell rating saying it’s ‘hard to see the upside.’ The broker notes certain high-grade ores which are more carbon efficient may encounter specific tailwinds in the new year.

Fortescue has been $18.81.

Invex Therapeutics (ASX:IXC) has had success simulating the use of Exenatide to improve cell survival in a 3D ‘human brain model’ of Alzheimer’s disease.

Invex Therapeutics has been 7.4 cents.

More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…